Roche Diagnostics has introduced a complete line of STAT immunoassays for cardiac biomarker testing on the cobas 6000 analyzer series, an integrated system designed for diagnostic labs with medium testing volumes.
The new 9-minute STAT immunoassay tests include troponin T, troponin I, CK-MB, myoglobin and NT-proBNP and run on the cobas e 601 analyzer, part of the cobas 6000 analyzer series, an integrated platform that offers both clinical chemistry and immunoassay testing.
Roche claims that with a 9-minute duration, the assays are faster than any other cardiac immunoassay tests currently available on an integrated platform and enable labs to deliver results to doctors treating cardiac patients in about half the time of standard Roche tests.
The cardiac STAT assays can all be run with one simple blood draw via Roche OneTUBE solution, which consists of a single lithium heparin tube that can be run on any of Roche’s integrated platforms.
Roche Diagnostics clinical development and education director Hans-Juergen Loyda said that in critical care environments that require rapid decision-making, this new line of STAT assays can help healthcare facilities meet current cardiac care turnaround time guidelines.
“Making the tests available on the cobas 6000 series gives labs the option to run Roche STAT assays on either stand-alone or integrated platforms.”